logo

For the Inventor, By the Inventor

Maidenhead, United Kingdom

Terence J Ward

This inventor holds 52 USPTO granted patents, primarily in Piperazine Derivatives (CPC class 5461). Top assignees: John Wyeth Brother, Limited, American Home Products Corporation, Other. Active years: 1976-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Terence J Ward. Retrieved from https://idiyas.com/inventor/terence-j-ward

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 52

% Patents Active = 100.0

Average Co-Inventor Count = 1.6

ph-index = 10

Forward Citations = 281(Granted Patents)

Forward Citations (Not Self Cited) = 242(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Slough, EN (1976)
  • Slough, GB (1978 - 1985)
  • Cippenham, Slough, Berkshire, GB (1986)
  • Cippenham, GB (1980 - 1988)
  • Maidenhead, GB (1986 - 1994)
  • Berks, GB (1995)
  • Reading, GB (1993 - 1998)

Company Filing History:

goldMedal49 out of 299 
 
John Wyeth Brother, Limited
 patents
silverMedal4 out of 1,567 
 
American Home Products Corporation
 patents
bronzeMedal1 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1976-1998

Loading Chart...
Areas of Expertise:
Piperazine Derivatives
Piperidine Compounds
Heterocyclic Chemistry
Indole Derivatives
Antidepressants
5-HT Antagonists
Carboxamides
Quinoline Compounds
Azabicyclo
Pharmacologically Active Amides
Benzoquinolizine Derivatives
Antipsychotic Agents
52 patents (USPTO):Explore Patents
1. 5763460 - N-(piperidinyl-1-alkyl)-substituted cyclohexane carboxylic acid amides (1998-06-09),
2. 5693642 - Piperazine derivatives as 5-HT.sub.1A ligands (1997-12-02),
3. 5622951 - Piperazine derivatives as 5-HT antagonists (1997-04-22),
4. 5610154 - Bicyclic carboxamides (1997-03-11),
5. 5436251 - Treatment of anxiety and gastrointestinal disorders with azabicyclo (1995-07-25),
6. 5430033 - Piperazine derivatives (1995-07-04),
7. 5362734 - Certain benzo-quinolizine compounds and derivatives thereof (1994-11-08),
8. 5346896 - 1-(aryl or heteroaryl)-4[.omega.-(aryl or heteroaryl).omega.-(aryl or (1994-09-13),
9. 5225419 - Certain 1,8-ethano or propano-1,4-dihydro-4-oxo-quinoline-3-carboxamides (1993-07-06),
10. 5212179 - Piperidine derivatives (1993-05-18),
11. 5177078 - Piperazine derivatives (1993-01-05),
12. 5106843 - Heterocyclic compounds useful as 5-HT.sub.3 antagonists (1992-04-21),
13. 5096901 - Pharmacologically active amides and esters containing an (1992-03-17),
14. 5068337 - 1,4-dihydropyridines and their ability to inhibit blood platelet (1991-11-26),
15. 5064842 - 1,4-dihydropyridines (1991-11-12),

Title: Terence J Ward - Pioneering Inventor from Maidenhead, GB

Introduction: Terence J Ward is a distinguished inventor hailing from Maidenhead, GB, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Terence J Ward holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his commitment to creating solutions for a better future.

Career Highlights: With over two decades of experience in the industry, Terence J Ward has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized various sectors.

Collaborations: Throughout his career, Terence J Ward has collaborated with top universities and multinational corporations to bring his innovative ideas to life, fostering a culture of creativity and excellence in the field of invention.

Conclusion: Terence J Ward's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the landscape of technology and inspiring future generations to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…